Back to top
VLS RETATRUTIDE 40MG
VLS RETATRUTIDE 40MG
VLS RETATRUTIDE 40MG VLS RETATRUTIDE 40MG

VLS RETATRUTIDE 40MG

800.0 INR/Piece

Product Details:

X

VLS RETATRUTIDE 40MG Price And Quantity

  • 800.0 INR/Piece
  • 5 Piece

VLS RETATRUTIDE 40MG Trade Information

  • 9979
  • Cash Against Delivery (CAD)
  • 50 Piece Per Year
  • 5 Days
  • Free samples are available
  • sealed
  • Asia, Australia, Central America, North America, South America, Eastern Europe
  • All India
  • Retatrutide is an investigational triple-receptor hormone agonist (targeting GLP-1, GIP, and glucagon receptors) developed by Eli Lilly. A 40mg vial or pen found online is an unapproved, unregulated research peptide or illicit product, as the medication is still undergoing Phase 3 clinical trials and lacks official therapeutic approval

Product Description

Retatrutide is an investigational triple-receptor hormone agonist (targeting GLP-1, GIP, and glucagon receptors) developed by Eli Lilly. A 40mg vial or pen found online is an unapproved, unregulated research peptide or illicit product, as the medication is still undergoing Phase 3 clinical trials and lacks official therapeutic approvalRetatrutide is an investigational triple-receptor hormone agonist (targeting GLP-1, GIP, and glucagon receptors) developed by Eli Lilly. A 40mg vial or pen found online is an unapproved, unregulated research peptide or illicit product, as the medication is still undergoing Phase 3 clinical trials and lacks official therapeutic approval
Retatrutide is an investigational triple-receptor hormone agonist (targeting GLP-1, GIP, and glucagon receptors) developed by Eli Lilly. A 40mg vial or pen found online is an unapproved, unregulated research peptide or illicit product, as the medication is still undergoing Phase 3 clinical trials and lacks official therapeutic approvalRetatrutide is an investigational triple-receptor hormone agonist (targeting GLP-1, GIP, and glucagon receptors) developed by Eli Lilly. A 40mg vial or pen found online is an unapproved, unregulated research peptide or illicit product, as the medication is still undergoing Phase 3 clinical trials and lacks official therapeutic approval






Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email